Jaundiced, n | Non-jaundiced, n | P value | |
---|---|---|---|
Male gender | 30 | 75 | 0.006 |
Mean age (range) | 58.04 ± 10.87 (35–80) | 59.21 ± 10.60 (23–83) | 0.478 |
Postoperative hospital stay | 18.31 ± 12.91 (4–85) | 10.92 ± 5.66 (5–51) | < 0.001 |
Associated gallbladder disease | 0.285 | ||
Gallstones | 24 (44.4%) | 116 (54.5%) | |
Gallbladder polyp | 1 (1.9%) | 2 (0.9%) | |
Nil | 29 (53.7%) | 95 (44.6%) | |
Tumor location | < 0.001 | ||
Gallbladder neck | 38 (70.4) | 29 (13.6) | |
Gallbladder body + fundus | 16 (29.6) | 184 (86.4) | |
Histologic type | 0.107 | ||
Moderately + well-differentiated | 51 (94.4) | 182 (85.4) | |
Poorly differentiated | 3 (5.6) | 31 (14.6) | |
Extent of liver resection | < 0.001 | ||
Major hepatectomy (> 3 segments) | 4 (7.4%) | 1 (0.6%) | |
Anatomical segments IV–V | 20 (37.0%) | 146 (68.5%) | |
Gallbladder bed | 30 (55.6%) | 66 (30.9%) | |
Extrahepatic bile duct resection | 54 (100.0%) | 20(9.4%) | < 0.001 |
Combined resection of adjacent organs | 9 (16.7%) | 9 (4.2%) | 0.003 |
Hepatic invasion | 29 (53.7%) | 100 (46.9%) | 0.446 |
Lymph node metastasis | 39 (72.2%) | 94 (44.1%) | < 0.001 |
Vascular invasion | 5(9.3%) | 0 (0%) | < 0.001 |
pT | 0.004 | ||
pT2 | 0 (0%) | 25 (11.7%) | |
pT3 | 45 (83.3%) | 174 (81.7%) | |
pT4 | 9(16.7%) | 14 (6.6%) | |
Intraoperative bleeding (ml) | 656.48 ± 532.97 (200–3200) | 329.67 ± 257.13 (200–1800) | < 0.001 |
Operative time (min) | 296.02 ± 76.91 (100–470) | 211.88 ± 80.10 (100–400) | < 0.001 |
Mortality (number of patients) | 2 (3.7%) | 1 (0.5%) | 0.105 |
Morbidity (need invasive treatment) | 15 (27.8%) | 13 (6.1%) | < 0.001 |